Syneos Health_rgb_r.jpg
INC Research/inVentiv Health to Present at Upcoming Jefferies 2017 London Healthcare Conference
03. November 2017 16:31 ET | INC Research, LLC
RALEIGH, N.C., Nov. 03, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive...
Syneos Health_rgb_r.jpg
INC Research/inVentiv Health Schedules Third Quarter 2017 Earnings Call for Thursday, November 9, 2017
19. Oktober 2017 17:02 ET | INC Research, LLC
RALEIGH, N.C., Oct. 19, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully-integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract...
Syneos Health_rgb_r.jpg
Investigative Sites Honor INC Research/inVentiv Health with 2017 Society for Clinical Research Sites Eagle Award
10. Oktober 2017 11:36 ET | INC Research, LLC
RALEIGH, N.C., Oct. 10, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization combining a CRO and CCO (Contract...
Syneos Health_rgb_r.jpg
INC Research/inVentiv Health to Present at Upcoming September Conferences
21. August 2017 17:01 ET | INC Research, LLC
RALEIGH, N.C., Aug. 21, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully-integrated biopharmaceutical solutions organization, today announced that Chief Financial...
Syneos Health_rgb_r.jpg
INC Research and inVentiv Health Announce Successful Completion of Merger
01. August 2017 09:12 ET | INC Research, LLC
Combination Creates the Only Fully Integrated Biopharmaceutical Solutions Organization with Combined Net Revenue of More Than $3 Billion Relaunch Under New Brand Planned for 2018 RALEIGH, N.C. and...
Syneos Health_rgb_r.jpg
INC Research and inVentiv Health to Merge
10. Mai 2017 06:03 ET | INC Research, LLC
Creates a Leading Global Biopharmaceutical Solutions Organization with Combined Net Revenue of More Than $3.2 Billion Combined Company Will Be Second Largest Biopharmaceutical Outsourcing Provider,...